John E. Kao, Chief Executive Officer at Alignment Healthcare, Inc. (ALHC), sold 1,070,036 shares at $16.42 ($17.6M) on 2025-09-10, disclosed to the SEC on 2025-09-10.
Scheduled sale ($17.6M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.23 | 253,908 | $4.1M | 23.5% |
| 2 | $16.23 | 253,908 | $4.1M | 23.5% |
| 3 | $16.42 | 180,000 | $3.0M | 16.8% |
| 4 | $16.42 | 180,000 | $3.0M | 16.8% |
| 5 | $16.86 | 101,110 | $1.7M | 9.7% |
| 6 | $16.86 | 101,110 |
| $1.7M |
| 9.7% |
| Total | $16.41 avg | 1,070,036 | $17.6M | 100% |
| Filing → |
| ALHC | SELL | 2026-08-10 | $4.1M | — | Filing → |
| ALHC | SELL | 2026-07-14 | $5.9M | — | Filing → |
| ALHC | SELL | 2026-06-12 | $6.1M | — | Filing → |